Product Information |
|
Registration Number |
BR-1289
|
Generic Name |
Rotavirus Vaccine (Live, Attenuated)
|
Brand Name |
Rotasiil
|
Dosage Strength |
Formulation: After reconstitution, each dose (2.5 mL) contains:
Live Attenuated Bovine-Human Rotavirus Reassortant [G1, G2, G3, G4 and G9]* >10^5.6 FFU/Serotype *Grown on vero cells
|
Dosage Form |
Freeze-dried Powder for Oral Suspension
|
Classification |
Prescription Drug (RX)
|
Packaging |
Type I clear tubular glass vial + Type I glass vial x 2.5 mL (Citrate Bicarbonate buffer solution as diluent) (Box of 1's)
|
Pharmacologic Category |
-
|
Manufacturer |
Serum Institute of India Private Limited
|
Country of Origin |
India
|
Trader |
N/A
|
Importer |
Faberco Life Sciences Inc.
|
Distributor |
N/A
|
Application Type |
-
|
Issuance Date |
18 March 2022
|
Expiry Date |
08 February 2027
|